MindMed Files 8-K for Regulatory, Other Events

Ticker: DFTX · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1813814

Mind Medicine (Mindmed) Inc. 8-K Filing Summary
FieldDetail
CompanyMind Medicine (Mindmed) Inc. (DFTX)
Form Type8-K
Filed DateMar 7, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$100,000,000
Sentimentneutral

Sentiment: neutral

Topics: regulatory-disclosure, 8-k

TL;DR

MindMed filed an 8-K on March 7th covering regulatory and other events.

AI Summary

Mind Medicine (MindMed) Inc. filed an 8-K on March 7, 2024, to report on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company's principal executive offices are located at One World Trade Center, Suite 8500, New York, NY 10007.

Why It Matters

This 8-K filing provides updates on important company events and regulatory disclosures, which are crucial for investors to understand the company's current status and compliance.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not appear to contain significant negative news or immediate financial risks.

Key Players & Entities

  • Mind Medicine (MindMed) Inc. (company) — Registrant
  • March 7, 2024 (date) — Date of earliest event reported
  • One World Trade Center, Suite 8500 (location) — Principal Executive Offices Address
  • New York, New York (location) — Principal Executive Offices City and State
  • 10007 (zip_code) — Principal Executive Offices Zip Code

FAQ

What is the primary purpose of this 8-K filing for Mind Medicine (MindMed) Inc.?

The 8-K filing serves to report on Regulation FD disclosures, other events, and financial statements and exhibits for Mind Medicine (MindMed) Inc.

On what date was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on March 7, 2024.

Where are Mind Medicine (MindMed) Inc.'s principal executive offices located?

Mind Medicine (MindMed) Inc.'s principal executive offices are located at One World Trade Center, Suite 8500, New York, New York, 10007.

What is the Commission File Number for Mind Medicine (MindMed) Inc.?

The Commission File Number for Mind Medicine (MindMed) Inc. is 001-40360.

Under which section of the Securities Exchange Act of 1934 is this Current Report filed?

This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 739 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-03-07 06:56:00

Key Financial Figures

  • $100,000,000 — he "ATM Prospectus"), relating to up to $100,000,000 of the Company's common shares that may

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release, dated March 7, 2024 99.2 Investor Presentation, dated March 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 7, 2024 Mind Medicine (MindMed) Inc. By: /s/ Robert Barrow Name: Robert Barrow Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.